Documents
Application Sponsors
ANDA 090600 | LANNETT CO INC | |
Marketing Status
Over-the-counter | 001 |
Over-the-counter | 002 |
Application Products
001 | FOR SOLUTION;ORAL | 17GM/PACKET | 0 | GLYCOLAX | POLYETHYLENE GLYCOL 3350 |
002 | FOR SOLUTION;ORAL | 17GM/SCOOPFUL | 0 | GLYCOLAX | POLYETHYLENE GLYCOL 3350 |
FDA Submissions
| ORIG | 1 | AP | 2009-10-06 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 2011-10-21 | |
LABELING; Labeling | SUPPL | 7 | AP | 2012-06-07 | |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 4 | Null | 15 |
SUPPL | 7 | Null | 15 |
CDER Filings
LANNETT CO INC
cder:Array
(
[0] => Array
(
[ApplNo] => 90600
[companyName] => LANNETT CO INC
[docInserts] => ["",""]
[products] => [{"drugName":"GLYCOLAX","activeIngredients":"POLYETHYLENE GLYCOL 3350","strength":"17GM\/PACKET","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"},{"drugName":"GLYCOLAX","activeIngredients":"POLYETHYLENE GLYCOL 3350","strength":"17GM\/SCOOPFUL","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"10\/06\/2009","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/090600s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"GLYCOLAX","submission":"POLYETHYLENE GLYCOL 3350","actionType":"17GM\/PACKET","submissionClassification":"FOR SOLUTION;ORAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">No"},{"actionDate":"GLYCOLAX","submission":"POLYETHYLENE GLYCOL 3350","actionType":"17GM\/SCOOPFUL","submissionClassification":"FOR SOLUTION;ORAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 2009-10-06
)
)